More on AMRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $16.34 |
|
|||
| Open | $16.48 | ||||
| 52 Wk High | $0.19 | ||||
| 52 Wk Low | $0.07 | ||||
| Day High | $16.61 | ||||
| Day Low | $16.18 | ||||
| P/E | N/A | ||||
| EPS | $-0.01 | ||||
| Volume | 1,060,864 | ||||
- Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals
- Amneal reports positive interim results for Parkinson's drug CREXONT
- Amneal reports positive interim results for CREXONT in Parkinson's study
- Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
- Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
- Amneal receives FDA approval for romidepsin injection solution
- Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
- Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Amneal Pharmaceuticals (AMRX) PT Raised to $16 at Barclays
- Form 4 Amneal Pharmaceuticals, For: May 11 Filed by: Autor Deborah M.
Entities mentioned with AMRX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- 13D | View Related Stories »
- Show More...
